NDI Guidance Could Heighten Need To Protect DSHEA’s Intent – Harkin
This article was originally published in The Tan Sheet
Sen. Tom Harkin calls on dietary supplement industry firms to “be vigilant" in protecting their rights under the Dietary Supplement Health and Education Act once FDA publishes the new dietary ingredient notification guidance.
You may also be interested in...
The volume of noncompliant supplement ingredients on the market likely will prompt an uptick in enforcement after FDA releases its NDI notification guidance, which will draw attention to the problem, dietary supplement program chief Daniel Fabricant says.
Novartis appeals Excedrin case to NARB
Sens. Orrin Hatch and Tom Harkin are no strangers to dietary supplement firms as longtime champions for their interests, but for the first time they are members of the industry's congressional caucus.